7 Posts Not to Miss From the EHA 2025 – Nico Gagelmann
The European Hematology Association (EHA) 2025 events bring together global experts to explore the latest advances in hematology. This year features two major gatherings: the EHA Research Conference (March 17–20 in Málaga, Spain), focusing on transcriptional control and chromatin in hematopoiesis, and the 30th EHA Annual Congress (June 12–15 in Milan, Italy), a hybrid event showcasing cutting-edge research, clinical updates, and educational sessions.
EHA 2025 offers a unique platform for knowledge exchange, collaboration, and innovation in blood disorders and research.
Nico Gagelmann, Young National Society Ambassador at European Hematology Association (EHA) and Chair of the CAR-T for plasma cell disorder committee at The EBMT, shared following posts from EHA 2025 on X:
1. “The best way to learn is from and with different generations.”
2. “Friends make medicine, science and life better, better together”
3. “Amazing session at EHA2025 with Coleman Lindsley and Mike Spencer Chapman chaired by Anna Sureda on
– Donor selection in families with recurreny myeloid mutations / Donor clonal hematopoiesis and recipient outcomes after transplantation
– Philogenetics of donor derived hematopoiesis”
4. “Fresh start with Clonal Hematopoiesis at last day of EHA2025 with Mikko Myllymäki”
5. “Excellent presentation by Carmelo Gurnari on the clinico genomic features of therapy-related myeloid neoplasm in EHA2025.”
6. “Fascinating European Hematology Association and The EBMT session at EHA2025 chaired by
Anna Sureda and Konstanze Döhner covering
New strategies for mismatched SCT (advances in donor selection and immunosuppression) by F Ciceri
The role of CAR-T as bridging to SCT (CAR-T vs SCT, or CAR-T and SCT?) by MariSubklewe
Outpatient CAR-T by Alexandra Martínez-Roca”
7. “Amazing Young EHA session at EHA2025 on critical appraisal of trialsSurrogates by Come Bommier.
Trial interpretation Eddie Cliff
And much more giving food for brain.”
Find more posts featuring EHA 2025 on Hemostasis Today.
-
Jun 15, 2025, 11:1710 Posts Not to Miss from EHA 2025
-
Jun 15, 2025, 09:44WFH Shared Decision-Making Tool: Help Improve Hemophilia Care
-
Jun 15, 2025, 06:52Pregnancy and Hereditary Antithrombin Deficiency: New Study Reveals Critical Clearance Peaks at Delivery
-
Jun 13, 2025, 23:12The ISTH proudly presents the Harold R. Roberts Award to Dr. Robert R. Montgomery
-
Jun 13, 2025, 08:19Decoding the Inflammatory–Metabolic Axis in Atherosclerosis: A New Frontier in Cardiovascular Prevention- by Atherosclerosis
-
Jun 15, 2025, 09:32Silent Threat: Underrated Risk of Thrombosis in IBD Outpatients Revealed by New Data - Thrombosis Update
-
Jun 13, 2025, 07:543-Year Outcomes of AAV Gene Therapy in Hemophilia B: Study Published in NEJM Shows Long-Term Factor IX Expression
-
Jun 12, 2025, 06:59DOACs vs. Warfarin in Cerebral Venous Thrombosis: ACTION-CVT Study Shows Safer Profile Without Compromising Efficacy
-
Jun 8, 2025, 14:49Shematologist Highlights Iron Deficiency's Impact on Mental Health in Young Females
-
Jun 7, 2025, 10:28IL-10 From Tumoral B Cells Modulates the Diffuse Large B-Cell Lymphoma Microenvironment and Response to Immunotherapy
-
Mar 6, 2025, 17:15Olympus Announces Launch of Single-Use Hemostasis Clip
-
Jun 11, 2025, 08:42Unmasking Thrombocytosis: What a High Platelet Count Really Means
-
Jun 7, 2025, 12:50ASH Sends a Letter to Senate Leaders Urging Them to Reject Harmful Medicaid Changes
-
Jun 7, 2025, 12:41ISTH - Abstracts for ISTH2025 are now LIVE
-
Jun 7, 2025, 12:29ASH - The Future of Classical Hematology is In Excellent Hands
-
Jun 7, 2025, 10:48Join Us For the Bleeding Disorders Conference 2025 - National Bleeding Disorders Foundation